Archives of Neuroscience

Published by: Kowsar

Preliminary Study of Differences Between Prevalence of Multiple Sclerosis in Isfahan and its’ Rural Provinces

Zahra Tolou-Ghamari 1 , *
Author Information
1 Isfahan Neurosciences Research Centre, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Archives of Neuroscience: October 2015, 2 (4); e60043
  • Published Online: October 10, 2015
  • Article Type: Research Article
  • Received: April 5, 2015
  • Accepted: May 9, 2015
  • DOI: 10.5812/archneurosci.29034

To Cite: Tolou-Ghamari Z. Preliminary Study of Differences Between Prevalence of Multiple Sclerosis in Isfahan and its’ Rural Provinces, Arch Neurosci. 2015 ; 2(4):e60043. doi: 10.5812/archneurosci.29034.

Abstract
Copyright © 2015, Tehran University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Ganesh A, Stahnisch FW. A history of multiple sclerosis investigations in Canada between 1850 and 1950. Can J Neurol Sci. 2014; 41(3): 320-32[PubMed]
  • 2. Tolou-Ghamari Z. A Review of Geoepidemiological Differences of Multiple Sclerosis in Iran and Other Middle East Countries. Arch Neurosci. 2014; 2(3)[DOI]
  • 3. Al Tahan AM, Alsharoqi I, Bohlega SA, Dahdaleh M, Daif A, Deleu D, et al. Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region. Int J Neurosci. 2014; 124(9): 635-41[DOI][PubMed]
  • 4. Benamer HT, Ahmed ES, Al-Din AS, Grosset DG. Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci. 2009; 278(1-2): 1-4[DOI][PubMed]
  • 5. Akhtar N, Elsetouhy A, Deleu D, Kamran S, AlHail H, Elalamy O, et al. Newly diagnosed multiple sclerosis in state of Qatar. Clin Neurol Neurosurg. 2013; 115(8): 1333-7[DOI][PubMed]
  • 6. Lauer K. Notes on the epidemiology of multiple sclerosis, with special reference to dietary habits. Int J Mol Sci. 2014; 15(3): 3533-45[DOI][PubMed]
  • 7. Kingwell E, Marriott JJ, Jette N, Pringsheim T, Makhani N, Morrow SA, et al. Incidence and prevalence of multiple sclerosis in Europe: a systematic review. BMC Neurol. 2013; 13: 128[DOI][PubMed]
  • 8. Boiko AN, Kukel TM, Lysenko MA, Vdovichenko TV, Gusev EI. Clinical epidemiology of multiple sclerosis in Moscow. capital ES, Cyrilliclinical demo-graphic characteristics in population of one region of Moscow [in Russian]. Zh Nevrol Psikhiatr Im S S Korsakova. 2014; 114(2 Vypusk 2 Rasseiannyi skleroz): 10-5[PubMed]
  • 9. Zsiros V, Fricska-Nagy Z, Fuvesi J, Kincses ZT, Langane E, Paulik E, et al. Prevalence of multiple sclerosis in Csongrad County, Hungary. Acta Neurol Scand. 2014; 130(5): 277-82[DOI][PubMed]
  • 10. Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, et al. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler. 2014; 20(6): 660-8[DOI][PubMed]
  • 11. Wallin MT, Culpepper WJ, Coffman P, Pulaski S, Maloni H, Mahan CM, et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain. 2012; 135: 1778-85[DOI][PubMed]
  • 12. Langer-Gould A, Brara SM, Beaber BE, Zhang JL. Incidence of multiple sclerosis in multiple racial and ethnic groups. Neurology. 2013; 80(19): 1734-9[DOI][PubMed]
  • 13. Amezcua L, Chung RH, Conti DV, Langer-Gould AM. Vitamin D levels in Hispanics with multiple sclerosis. J Neurol. 2012; 259(12): 2565-70[DOI][PubMed]
  • 14. Siegel M, Paperna T, Lejbkowicz I, Petrou P, Shahien R, Karussis D, et al. Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel. Mult Scler. 2012; 18(12): 1737-44[DOI][PubMed]
  • 15. Sharafaddinzadeh N, Moghtaderi A, Majdinasab N, Dahmardeh M, Kashipazha D, Shalbafan B. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs. Clin Neurol Neurosurg. 2013; 115(8): 1271-5
  • 16. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013; 70(5-6): 356-63[DOI][PubMed]
  • 17. Harbo HF, Gold R, Tintore M. Sex and gender issues in multiple sclerosis. Ther Adv Neurol Disord. 2013; 6(4): 237-48[DOI][PubMed]
  • 18. McLeod JG, Hammond SR, Kurtzke JF. Migration and multiple sclerosis in United Kingdom and Ireland immigrants to Australia: a reassessment. II. Characteristics of early (pre-1947) compared to later migrants. J Neurol. 2012; 259(4): 684-93[DOI][PubMed]
  • 19. Tolou-Ghamari Z, Shaygannejad V, Ashtari F. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital. Int J Prev Med. 2013; 4-8[PubMed]
  • 20. Orton SM, Ramagopalan SV, Brocklebank D, Herrera BM, Dyment DA, Yee IM, et al. Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study. J Neurol Neurosurg Psychiatry. 2010; 81(1): 31-6[DOI][PubMed]
  • 21. Guimond C, Dyment DA, Ramagopalan SV, Giovannoni G, Criscuoli M, Yee IM, et al. Prevalence of MS in Iranian immigrants to British Columbia, Canada. J Neurol. 2010; 257(4): 667-8[DOI][PubMed]
  • 22. van Leeuwen MT, Turner JJ, Falster MO, Meagher NS, Joske DJ, Grulich AE, et al. Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure. Int J Cancer. 2013; 133(4): 944-51[DOI][PubMed]
  • 23. Hart PH, Gorman S. Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible? Clin Biochem Rev. 2013; 34(1): 3-13[PubMed]
  • 24. Lossius A, Riise T, Pugliatti M, Bjornevik K, Casetta I, Drulovic J, et al. Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study. Mult Scler. 2014; 20(6): 669-74[DOI][PubMed]
  • 25. Robinson C, Stern F, Halperin W, Venable H, Petersen M, Frazier T, et al. Assessment of mortality in the construction industry in the United States, 1984-1986. Am J Ind Med. 1995; 28(1): 49-70[PubMed]
  • 26. Lauer K. Risk of multiple sclerosis in relation to industrial activities: an ecological study in four European countries. Neuroepidemiology. 1989; 8(1): 38-42[PubMed]
  • 27. Riise T, Moen BE, Kyvik KR. Organic solvents and the risk of multiple sclerosis. Epidemiology. 2002; 13(6): 718-20[DOI][PubMed]
  • 28. Landtblom AM, Flodin U, Karlsson M, Palhagen S, Axelson O, Soderfeldt B. Multiple sclerosis and exposure to solvents, ionizing radiation and animals. Scand J Work Environ Health. 1993; 19(6): 399-404[PubMed]
  • 29. Gronning M, Albrektsen G, Kvale G, Moen B, Aarli JA, Nyland H. Organic solvents and multiple sclerosis: a case-control study. Acta Neurol Scand. 1993; 88(4): 247-50[PubMed]
  • 30. Lauer K. Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies. Acta Neurol Scand Suppl. 1995; 161: 77-88[PubMed]
  • 31. Stein EC, Schiffer RB, Hall WJ, Young N. Multiple sclerosis and the workplace: report of an industry-based cluster. Neurology. 1987; 37(10): 1672-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments